Literature DB >> 8550195

Functional analysis of pneumolysin by use of monoclonal antibodies.

J R de los Toyos1, F J Méndez, J F Aparicio, F Vázquez, M Del Mar García Suárez, A Fleites, C Hardisson, P J Morgan, P W Andrew, T J Mitchell.   

Abstract

We have produced a panel of monoclonal antibodies to pneumolysin, the membrane-damaging toxin from Streptococcus pneumoniae. We have used these antibodies to identify three regions of the toxin sequence that are involved in the lytic mechanism of this toxin. Two of these sites probably form the cell binding site of this toxin. Antibodies to the third site inhibit the lytic action of this toxin but not the binding of this toxin to cells. This site is engaged in the oligomerization process involved in the formation of pores in cell membranes. Two of these epitopes are also present in the related toxin perfringolysin O.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8550195      PMCID: PMC173789          DOI: 10.1128/iai.64.2.480-484.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Expression of the pneumolysin gene in Escherichia coli: rapid purification and biological properties.

Authors:  T J Mitchell; J A Walker; F K Saunders; P W Andrew; G J Boulnois
Journal:  Biochim Biophys Acta       Date:  1989-01-23

Review 2.  Structure and function of pneumolysin, the multifunctional, thiol-activated toxin of Streptococcus pneumoniae.

Authors:  G J Boulnois; J C Paton; T J Mitchell; P W Andrew
Journal:  Mol Microbiol       Date:  1991-11       Impact factor: 3.501

3.  The antigenic index: a novel algorithm for predicting antigenic determinants.

Authors:  B A Jameson; H Wolf
Journal:  Comput Appl Biosci       Date:  1988-03

4.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity.

Authors:  S Rath; C M Stanley; M W Steward
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

6.  Use of a monoclonal antibody to determine the mode of transmembrane pore formation by streptolysin O.

Authors:  F Hugo; J Reichwein; M Arvand; S Krämer; S Bhakdi
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  The pathogenesis of pneumococcal infection in mice.

Authors:  T B Dick; C G Gemmell
Journal:  J Med Microbiol       Date:  1971-05       Impact factor: 2.472

8.  Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O.

Authors:  F Nato; K Reich; S Lhopital; S Rouyre; C Geoffroy; J C Mazie; P Cossart
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

9.  Mapping of immunoreactive sites of pneumococcal pneumolysin by use of synthetic peptides.

Authors:  P Salo; A Närvänen; M Leinonen
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

Review 10.  Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins.

Authors:  J C Paton; P W Andrew; G J Boulnois; T J Mitchell
Journal:  Annu Rev Microbiol       Date:  1993       Impact factor: 15.500

View more
  18 in total

1.  Identification of invasive serotype 1 pneumococcal isolates that express nonhemolytic pneumolysin.

Authors:  Lea-Ann S Kirkham; Johanna M C Jefferies; Alison R Kerr; Yu Jing; Stuart C Clarke; Andrew Smith; Tim J Mitchell
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Competence-programmed predation of noncompetent cells in the human pathogen Streptococcus pneumoniae: genetic requirements.

Authors:  Sébastien Guiral; Tim J Mitchell; Bernard Martin; Jean-Pierre Claverys
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-31       Impact factor: 11.205

3.  Streptococcus pneumoniae-induced inhibition of rat ependymal cilia is attenuated by antipneumolysin antibody.

Authors:  Robert A Hirst; Bashir J Mohammed; Timothy J Mitchell; Peter W Andrew; Christopher O'Callaghan
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

Review 4.  Listeria pathogenesis and molecular virulence determinants.

Authors:  J A Vázquez-Boland; M Kuhn; P Berche; T Chakraborty; G Domínguez-Bernal; W Goebel; B González-Zorn; J Wehland; J Kreft
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

5.  Oriented immobilization of anti-pneumolysin tagged recombinant antibody fragments.

Authors:  Maria del Mar Garcia-Suarez; Roberto Villaverde; Irene Gonzalez-Rodriguez; Fernando Vazquez; Francisco J Mendez
Journal:  Curr Microbiol       Date:  2009-03-28       Impact factor: 2.188

6.  Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.

Authors:  Lea-Ann S Kirkham; Alison R Kerr; Gill R Douce; Gavin K Paterson; Deborah A Dilts; Dai-Fang Liu; Tim J Mitchell
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 7.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

8.  Neutralizing antibodies elicited by a novel detoxified pneumolysin derivative, PlyD1, provide protection against both pneumococcal infection and lung injury.

Authors:  Danielle Salha; Jason Szeto; Lisa Myers; Carol Claus; Anthony Sheung; Mei Tang; Belma Ljutic; David Hanwell; Karen Ogilvie; Marin Ming; Benjamin Messham; Germie van den Dobbelsteen; Robert Hopfer; Martina M Ochs; Scott Gallichan
Journal:  Infect Immun       Date:  2012-04-02       Impact factor: 3.441

9.  Crucial role of perfringolysin O D1 domain in orchestrating structural transitions leading to membrane-perforating pores: a hydrogen-deuterium exchange study.

Authors:  Aleksandra Kacprzyk-Stokowiec; Magdalena Kulma; Gabriela Traczyk; Katarzyna Kwiatkowska; Andrzej Sobota; Michał Dadlez
Journal:  J Biol Chem       Date:  2014-08-27       Impact factor: 5.157

10.  Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.

Authors:  María del Mar García-Suárez; María Dolores Cima-Cabal; Noelia Flórez; Pilar García; Rafael Cernuda-Cernuda; Aurora Astudillo; Fernando Vázquez; Juan R De los Toyos; F Javier Méndez
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.